MICHELLE BRILEY: Open Payments
NPI 1336789387 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 43 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $54 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $159 |
| Lilly USA, LLC | 6 | $103 |
| AstraZeneca Pharmaceuticals LP | 5 | $74 |
| Amgen Inc. | 4 | $56 |
| PFIZER INC. | 3 | $54 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Novo Nordisk Inc | 2 | $29 |
| Boston Scientific Corporation | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: QULIPTA, MOUNJARO, VRAYLAR, EVENITY, FARXIGA, NURTEC ODT, JARDIANCE, BREZTRI.
Industry payments across MS — which companies pay providers there.
